secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001829126-26-003733
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical Q1 preliminary revenue up 79.9% to $1.1M; driven by STAH sales
-----------------------------------------------------------------------------

- Preliminary unaudited revenue of $1.1M for Q1 2026 vs $0.6M in Q1 2025, a 79.9% increase.
- Growth driven by higher SynCardia Total Artificial Heart (STAH) sales, favorable U.S. reimbursement, and pricing adjustments on driver rentals.
- CEO cites progress in commercial initiatives and increased STAH utilization as bridge-to-transplant.
- Full Q1 results to be filed in Form 10-Q on or before May 15, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626003733/0001829126-26-003733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626003733/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-003733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer